Yogen Saunthararajah

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 19

Top Venues

Leukemia

Clinical case reports

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Donald Lavelle, Vinzon Ibanez, Kestis Vaitkus, Xu Zhang, Jagadeesh Ramasamy, Angela E Rivers, Yogen Saunthararajah, Robert Molokie
Combinatorial targeting of epigenome-modifying enzymes with small molecule drugs synergistically increases HbF. Blood advances (2023)
David Levitz, Yogen Saunthararajah, Kateryna Fedorov, Lauren C Shapiro, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R Alejandro Sica, Nishi Shah, Marina Y Konopleva, Kira Gritsman, Ira Braunschweig, Dennis L Cooper, Kith Pradhan, Amit K Verma, Eric J Feldman, Mendel Goldfinger
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Henry Lau, Philip G Woost, Ute Friedrich, Wan Hui Ong Clausen, James W Jacobberger, Yogen Saunthararajah
Pharmacokinetics and pharmacodynamics of an oral formulation of decitabine and tetrahydrouridine. European journal of haematology (2023)
Nikolaus von Knebel Doeberitz, Daniel Paech, Dominik Sturm, Stefan Pusch, Sevin Turcan, Yogen Saunthararajah
Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas. International journal of cancer 151 (9) (2022)
Simona Pagliuca, Carmelo Gurnari, Hassan Awada, Ashwin Kishtagari, Sunisa Kongkiatkamon, Laila Terkawi, Misam Zawit, Yihong Guan, Thomas LaFramboise, Babal Kant Jha, Bhumika J Patel, Betty K Hamilton, Navneet S Majhail, Sofie A Lundgren, Mohamed El Missiry, Yogen Saunthararajah, Valeria Visconte, Timothy Chan, Chao-Yie Yang, Tobias Lenz, Jaroslaw P Maciejewski
The Similarity of Class II HLA Genotypes Defines Patterns of Autoreactivity in Idiopathic Bone Marrow Failure Disorders. Blood (2021)
L C Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, Tammy Stefan, Kalpana Gupta, Xuan Xu, Slim Fourati, Anne Roe, Zachary Jackson, Robert Schauner, Ashish Sharma, Banumathi Tamilselvan, Samuel Li, Marcos J deLima, Tae Hyun Hwang, Robert Balderas, Yogen Saunthararajah, Jaroslaw Maciejewski, Thomas LaFramboise, Jill S Barnholtz-Sloan, Rafick-Pierre Sekaly, David N Wald
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia 35 (10) (2021)
Misam Zawit, Carmelo Gurnari, Simona Pagliuca, Hassan Awada, Jaroslaw P Maciejewski, Yogen Saunthararajah
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia. Clinical case reports 9 (9) (2021)
Phaedon D Zavras, Aditi Shastri, Mendel Goldfinger, Amit K Verma, Yogen Saunthararajah
Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Hassan Awada, Arda Durmaz, Carmelo Gurnari, Ashwin Kishtagari, Manja Meggendorfer, Cassandra M Kerr, Teodora Kuzmanovic, Jibran Durrani, Jacob Shreve, Yasunobu Nagata, Tomas Radivoyevitch, Anjali S Advani, Farhad Ravandi, Hetty E Carraway, Aziz Nazha, Claudia Haferlach, Yogen Saunthararajah, Jacob G Scott, Valeria Visconte, Hagop Kantarjian, Tapan Kadia, Mikkael A Sekeres, Torsten Haferlach, Jaroslaw P Maciejewski
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia. Blood 138 (19) (2021)
Sunisa Kongkiatkamon, Simona Pagliuca, Vera Adema, Yasunobu Nagata, Cassandra M Kerr, Wencke Walter, Hassan Awada, Stephan Hutter, Carmelo Gurnari, Heesun Joyce Rogers, Manja Meggendorfer, Yogen Saunthararajah, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. Leukemia (2021)
Sheelarani Karunanithi, Ruifu Liu, Yongchun Hou, Giancarlo Gonzalez, Natasha Oldford, Anne Jessica Roe, Nethrie Idipilly, Kalpana Gupta, Chandra Sekhar Amara, Satwikreddy Putluri, Grace Kyueun Lee, Juan Valentin-Goyco, Lindsay Stetson, Stephen A Moreton, Vasanta Putluri, Shyam M Kavuri, Yogen Saunthararajah, Marcos de Lima, Gregory P Tochtrop, Nagireddy Putluri, David N Wald
Thioredoxin reductase is a major regulator of metabolism in leukemia cells. Oncogene 40 (33) (2021)
Hassan Awada, Cassandra M Kerr, Arda Durmaz, Vera Adema, Carmelo Gurnari, Simona Pagliuca, Misam Zawit, Sunisa Kongkiatkamon, Heesun J Rogers, Yogen Saunthararajah, Mikkael A Sekeres, Hetty E Carraway, Jaroslaw P Maciejewski, Valeria Visconte
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations. Leukemia 35 (11) (2021)
Yihong Guan, Edward F Greenberg, Metis Hasipek, Shi Chen, Xiaochen Liu, Cassandra M Kerr, Ryszard Olinski, Ewelina Zarakowska, Tomas Radivoyevitch, Xiaorong Gu, Belinda Willard, Valeria Visconte, Hideki Makishima, Aziz Nazha, Mridul Mukherji, Mikkael A Sekeres, Yogen Saunthararajah, Ryszard Oliński, Mingjiang Xu, Jaroslaw P Maciejewski, Babal Kant Jha
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia. Communications biology 3 (1) (2020)
Xiaorong Gu, Rita Tohme, Benjamin Tomlinson, Nneha Sakre, Metis Hasipek, Lisa Durkin, Caroline Schuerger, Dale Grabowski, Asmaa M Zidan, Tomas Radivoyevitch, Changjin Hong, Hetty Carraway, Betty Hamilton, Ronald Sobecks, Bhumika Patel, Babal Kant Jha, Eric D Hsi, Jaroslaw Maciejewski, Yogen Saunthararajah
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network. Leukemia 35 (4) (2020)
Xiaorong Gu, Yogen Saunthararajah
Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukaemia is obscured by paraformaldehyde fixation. British journal of haematology 189 (3) (2020)
Jong Jin Jeong, Xiaorong Gu, Ji Nie, Sriram Sundaravel, Hui Liu, Wen-Liang Kuo, Tushar D Bhagat, Kith Pradhan, John Cao, Sangeeta Nischal, Kathy L McGraw, Sanchari Bhattacharyya, Michael R Bishop, Andrew Artz, Michael J Thirman, Alison R Moliterno, Peng Ji, Ross L Levine, Lucy A Godley, Ulrich Steidl, James J Bieker, Alan F List, Yogen Saunthararajah, Chuan He, Amit Verma, Amittha Wickrema
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis. Cancer discovery 9 (6) (2019)
Hassan Awada, Reda Z Mahfouz, Ashwin Kishtagari, Teodora Kuzmanovic, Jibran Durrani, Cassandra M Kerr, Bhumika J Patel, Valeria Visconte, Tomas Radivoyevitch, Alan Lichtin, Hetty E Carraway, Jaroslaw P Maciejewski, Yogen Saunthararajah
Extended experience with a non-cytotoxic DNMT1-targeting regimen of decitabine to treat myeloid malignancies. British journal of haematology 188 (6) (2019)
Mostafa F M Saleh, Yogen Saunthararajah
Severe pyoderma gangrenosum caused by myelodysplastic syndrome successfully treated with decitabine administered by a noncytotoxic regimen. Clinical case reports 5 (12) (2017)
Robert Molokie, Donald Lavelle, Michel Gowhari, Michael Pacini, Lani Krauz, Johara Hassan, Vinzon Ibanez, Maria A Ruiz, Kwok Peng Ng, Philip Woost, Tomas Radivoyevitch, Daisy Pacelli, Sherry Fada, Matthew Rump, Matthew M Hsieh, John F Tisdale, James Jacobberger, Mitch A Phelps, James Douglas Engel, Santhosh Saraf, Lewis L Hsu, Victor Gordeuk, Joseph DeSimone, Yogen Saunthararajah
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLoS medicine 14 (9) (2017)

Yogen Saunthararajah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yogen Saunthararajah